Both in Pharmaceuticals
Revelation Biosciences vs GRI Bio
Over the past year REVB returned −90.6% and GRI returned −97.5%; their daily moves had a correlation of 0.07.
REVB −90.6% GRI −97.5%Growth of $1, one year, split-adjusted
| Metric | REVB | GRI |
|---|---|---|
| Price | $0.4847 | $1.38 |
| Market cap | $1.9M | $3.0M |
| Today | −36.41% | −1.43% |
| 1 month | −49.0% | −25.0% |
| 6 months | −57.7% | −45.9% |
| Year to date | −84.8% | −80.0% |
| 1 year | −91.1% | −97.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.5M | $10.9M |
| Dividend yield | — | — |
| Volatility (60d) | 112.1% | 135.7% |
| Short % of float | 0.0% | 3.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).